| Application no. and date | 15742306.2 (espacenet) (Federated) (European Patent Register), 20150729 | | Patent/reg. no. and date | DK/EP 3174875, 20200819 | | Publication date | 20170607 | | Priority no. and date | EP 14179544, 20140801 | | EP pub. no. and date |
EP 3174875 20170607 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | 1553837 | | Inventor | PLATZEK, Johannes, Grottkauer Str. 55
12621 Berlin, DE,
GRUNENBERG, Alfons, Bismarckstr. 87
42115 Wuppertal, DE,
GARKE, Gunnar, Friesenstr. 12
42719 Solingen, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61P 9/00 (2006.01) , C07D 471/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOX-AMID OG DETS OPRENSNING TIL ANVENDELSE SOM FARMACEUTISK AKTIVSTOF | | Int. application no. | EP2015067340 | | Int. publication no. | WO2016016287 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
